cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Forte Biosciences Inc
8 own
5 watching
Current Price
$14.7
$-0.9
(-5.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
10.95M
52-Week High
52-Week High
28.68000
52-Week Low
52-Week Low
4.11000
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization10.95M
icon52-Week High28.68000
icon52-Week Low4.11000
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio--
What does the Forte Biosciences Inc do?
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases. The Company is advancing its product candidate, FB-102, which is a proprietary molecule with potentially broad autoimmune applications, including in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA). The Company’s FB-102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and T cell subsets. It owns one United States patent for administering a combination of Gram-positive and Gram-negative bacteria along with metabolites for treatment of a wide variety of skin conditions. The Company’s subsidiaries include Forte Subsidiary, Inc., Forte Biosciences Emerald Limited, and Forte Biosciences Australia Pty Ltd.
Read More
How much money does Forte Biosciences Inc make?
News & Events about Forte Biosciences Inc.
Ticker Report
1 year ago
Forte Biosciences (NASDAQ:FBRX Get Rating) and Kezar Life Sciences (NASDAQ:KZR Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability...
Ticker Report
2years ago
Forte Biosciences, Inc. (NASDAQ:FBRX Get Rating) was the recipient of unusually large options trading on Wednesday. Traders purchased 30,205 call options on the company. This represents an increase of 1,663% compared to the typical volume of 1,713 call options. Forte Biosciences Trading Up 2...
Business Wire
2years ago
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases today announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules. In accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation...
Business Wire
2years ago
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases announces that Dr. Hubert Chen, MD has joined the company as Chief Scientific Officer and President. Dr. Chen is a very accomplished drug development scientist and physician and...
Business Wire
2years ago
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced first quarter 2022 results and provided a business update. Following a very extensive process by our Board, the management team and external advisors, Forte is...
Frequently Asked Questions
Frequently Asked Questions
What is Forte Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Forte Biosciences Inc shares?
plus_minus_icon
How can I buy Forte Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Forte Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Forte Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Forte Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Forte Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Forte Biosciences Inc?
plus_minus_icon
What percentage is Forte Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Forte Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$14.7
$-0.9
(-5.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$78.26
$7.72 (10.94 %)
CABALETTA BIO INC
CABALETTA BIO INC
$2.60
$-0.14 (-5.11 %)
ALIGOS THERAPEUTICS INC
ALIGOS THERAPEUTICS INC
$33.79
$-0.45 (-1.31 %)
Applied Therapeutics Inc
Applied Therapeutics Inc
$0.66
$0.00 (0.34 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$78.26
$7.72 (10.94 %)
CABALETTA BIO INC
CABALETTA BIO INC
$2.60
$-0.14 (-5.11 %)
ALIGOS THERAPEUTICS INC
ALIGOS THERAPEUTICS INC
$33.79
$-0.45 (-1.31 %)
Applied Therapeutics Inc
Applied Therapeutics Inc
$0.66
$0.00 (0.34 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00